Company: LGN
Filing Date: 2025-04-30
Form Type: DRS/A
Source: 0000950123-25-003868
Chunk: 314

Company: Legence Corp.
Filing Date: 2025-04-30
Form: DRS/A
Chunk 314
---
, total guarantees were $308.2 million and $322.0 million, respectively. Historically, the Company has not incurred material losses in connection with these guarantees. Further, management is not aware of any changes in the ability of the Company to meet these guarantees and does not expect to incur significant losses related to these guarantees in the foreseeable future. Letters of Credit As discussed in “ Note 9—Debt,” the standby letters of credit are secured through the revolving line of credit. As of both December 31, 2024 and 2023, the Company had $5.2 million in standby letters of credit primarily related to the deductibles of insurance policies. Note 19—Other Financial Information Cash and cash equivalents and restricted cash consists of the following (in thousands):

|                                               |     | December 31, |   2024 |     |   |   2023 |     |   |   2022 |
|:----------------------------------------------|:----|:-------------|-------:|:----|:--|-------:|:----|:--|-------:|
| Cash and cash equivalents                     |     | $            | 81,167 |     | $ | 88,920 |     | $ | 13,902 |
| Restricted cash                               |     |              |      — |     |   |      — |     |   | 46,532 |
| Cash and cash equivalents and restricted cash |     | $            | 81,167 |     | $ | 88,920 |     | $ | 60,434 |

Restricted cash as of December 31, 2022 represents debt proceeds designated for acquisition-related payments. Accounts receivable, net consists of the following (in thousands):

|                           |     | December 31, |    2024 |     |   |    2023 |
|:--------------------------|:----|:-------------|--------:|:----|:--|--------:|
| Contracts receivable, net |     | $            | 441,109 |     | $ | 414,876 |
| Accounts receivable—other |     |              |   7,501 |     |   |   7,816 |
| Accounts receivable, net  |     | $            | 448,610 |     | $ | 422,692 |

F-57

Confidential Treatment Requested by Legence Corp. Pursuant to 17 C.F.R. Section 200.83 Leg